Newsroom

Sorted by: Latest

-

Rivia Expands Clinical Trial Intelligence Platform with New AI-Powered Data Findings Module

ZURICH--(BUSINESS WIRE)--Rivia Expands Clinical Trial Intelligence Platform with New AI-Powered Data Findings Module...
-

Ralph Lauren Reports Second Quarter Fiscal 2027 Results Ahead of Expectations and Raises Fiscal 2027 Outlook

NEW YORK--(BUSINESS WIRE)--RALPH LAUREN REPORTS SECOND QUARTER FISCAL 2027 RESULTS AHEAD OF EXPECTATIONS AND RAISES FISCAL 2027 OUTLOOK...
-

XiFin Earns Third Consecutive HITRUST r2 Certification for XiFin Empower RCM and Recertifies Pharmacy Platforms Under HITRUST i1

SAN DIEGO--(BUSINESS WIRE)--XiFin, Inc., a healthcare information technology company providing AI-enabled revenue cycle management and related technology to diagnostic laboratories, pathology groups, radiology practices, hospital outreach programs, and pharmacies, today announced that the XiFin®Empower RCM System has achieved HITRUST Risk-based, 2-year (r2) Certified status for the third consecutive two-year term. XiFin also announced that its Pharmacy Documentation and Workflow System, Clinical...
-

Centuri Reports Third Quarter 2026 Results, Achieves Record Quarterly Revenue & Gross Profit and Delivers Margin Expansion

PHOENIX--(BUSINESS WIRE)--Centuri Holdings, Inc. (NYSE: CTRI) ("Centuri" or the "Company") today announced financial and operating results for the third quarter ended September 27, 2026. Third Quarter 2026 Results and Highlights Achieved company record quarterly Revenue of $1.2 billion, a 40% increase versus the third quarter of 2025 Produced record quarterly Gross Profit of $113.4 million, a 45% increase from the same period last year Delivered a Gross Profit margin of 9.5%, up from 9.2% in th...
-

Lineage Cell Therapeutics to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

CARLSBAD, Calif.--(BUSINESS WIRE)--Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company novel, allogeneic, “off the shelf”, cell therapies for serious medical conditions, today announced that it will report its third quarter 2026 financial and operating results on November 12, 2026, following the close of the U.S. financial markets. Lineage management will also host a conference call and webcast on November 12, 2026, at 4:30 p.m. Eastern Time/1:...
-

FORE Biotherapeutics to Participate in Upcoming Investor Conferences

PHILADELPHIA--(BUSINESS WIRE)--FORE Biotherapeutics today announced that the Company will participate at the following investor conferences: Stifel 2026 Healthcare Conference. The Company will attend on Thursday, November 12, and will provide a corporate presentation at 9:20 a.m. – 9:50 a.m. ET. Jefferies 2026 Global Healthcare Conference in London. The Company will attend and participate in one-on-one meetings from Monday, November 16 – Wednesday, November 18. Management will host and particip...
-

USA TODAY Co. Announces Third Quarter Results, $100 Million Cost Reduction Program & Plans to Opportunistically Repurchase Shares

NEW YORK, NY--(BUSINESS WIRE)--USA TODAY Co., Inc. ("USA TODAY Co.", "we", "us", "our", or the "Company") (NYSE: TDAY) today reported its financial results for the third quarter ended September 30, 2026. "In the third quarter, we felt the impacts of the changes in consumer search along with some inflationary pressures. At the same time, we saw encouraging underlying signals in the categories that we believe are most important to our future. Audience trends showed signs of stabilization, engagem...
-

Donaldson to Webcast First Quarter Fiscal 2027 Earnings Conference Call

MINNEAPOLIS--(BUSINESS WIRE)--Donaldson Company, Inc. (NYSE: DCI), a leading worldwide provider of innovative filtration products and solutions, will webcast its first quarter 2027 earnings conference call on Wednesday, December 2, 2026, at 9:00 a.m. CT. WEBCAST: To listen to a live webcast of the call, visit the “Events & Presentations” section of Donaldson’s Investor Relations website at IR.Donaldson.com and click on the “listen to webcast” option.   REPLAY: The webcast replay will be ava...
-

Blue Yonder Launches AI-Native Order Management to Help Retailers and Distributors Protect Sales and Lower Fulfillment Costs

DALLAS--(BUSINESS WIRE)--Blue Yonder, the AI company for supply chain, today launched its AI-native Order Management Solution as part of its Cognitive Solutions portfolio. It unifies every stage of an order, from the first delivery promise through fulfillment, customer service and returns. This helps retailers and distributors capture more revenue, lower fulfillment costs and keep their commitments to customers, even when priorities change.Order management becomes the connecting pointCommerce, p...
-

CION Investment Corporation Reports Third Quarter 2026 Financial Results

NEW YORK--(BUSINESS WIRE)--CION Investment Corporation (NYSE: CION) (“CION” or the “Company”) today reported financial results for the third quarter ended September 30, 2026 and filed its Form 10-Q with the U.S. Securities and Exchange Commission (the “SEC”). CION also announced that, on November 3, 2026, its co-chief executive officers declared base distributions totaling $0.25 per share for the first quarter of 2027, which will be payable to shareholders in the amount of $0.08, $0.08 and $0.0...